N-Ethylhexedrone was patented because of the German pharmaceutical company Boehringer Ingelheim in 1964 as a possible anorexigenic agent. The patent describes its synthesis together with other derivatives of aminoketone.[1] Which means that a negligible quantity of sample is required for corr